Kelly R. Thornburg
Corporate Officer/Principal bij CHIMERIC THERAPEUTICS LIMITED
Actieve functies van Kelly R. Thornburg
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
CHIMERIC THERAPEUTICS LIMITED | Corporate Officer/Principal | 03-02-2022 | - |
Loopbaan van Kelly R. Thornburg
Eerdere bekende functies van Kelly R. Thornburg
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
XBIOTECH INC. | Operationeel Directeur | 08-06-2015 | 05-05-2017 |
KITE PHARMA INC | Corporate Officer/Principal | - | - |
AMGEN INC. | Corporate Officer/Principal | - | - |
Opleiding van Kelly R. Thornburg
Rockhurst University | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 5 |
Australië | 2 |
Operationeel
Corporate Officer/Principal | 3 |
Chief Operating Officer | 1 |
Undergraduate Degree | 1 |
Sectoraal
Health Technology | 5 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
XBIOTECH INC. | Health Technology |
AMGEN INC. | Health Technology |
CHIMERIC THERAPEUTICS LIMITED | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Kite Pharma, Inc.
Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
- Beurs
- Insiders
- Kelly R. Thornburg
- Ervaring